The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Application of the French prognostic score (FPS) to assess overall survival (OS) in a U.S.-based cohort of patients (pts) treated with azacitidine (Aza).
Amer Zeidan
No relevant relationships to disclose
Zhuoxin Sun
No relevant relationships to disclose
Thomas Prebet
Research Funding - Celgene
Peter Greenberg
No relevant relationships to disclose
Mark Juckett
No relevant relationships to disclose
Mitchell Reed Smith
No relevant relationships to disclose
Elisabeth Paietta
No relevant relationships to disclose
Janice Lynn Gabrilove
No relevant relationships to disclose
Harry P. Erba
No relevant relationships to disclose
Steven Gore
Research Funding - Celgene
Martin S. Tallman
No relevant relationships to disclose